Log In
BCIQ
Print this Print this
 

SA-033

  Manage Alerts
Collapse Summary General Information
Company Double Bond Pharmaceutical International AB
DescriptionBelogal-delivered doxorubicin
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationLiver cancer
Indication DetailsTreat hepatoblastoma; Treat hepatocellular carcinoma (HCC); Treat liver metastases of other cancers
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today